The 0.30 is being tested almost every day.When you have traders/MM playing with this stock, they don't care what the price of the stock is- only the spread.
Until there is something more concrete (not just hype) this stock will have it's biggest test somewhere between Oct20-31st. I personally don't see anything substantive coming out.
FDA/Fluticare is currently nothing more than hype for the NA market place. I have more faith of approval in Europe coming before US (if US happens).
No one at this point can say without a doubt FDA approval is going to happen. I'd give it a 50:50 chance of it happening in Q1 of next year.
I'm just surprised there is no interim update on revenues (that bothers me).
News 
Market Data 
Discover 
